Results 1 to 10 of about 124,817 (274)

Medullary thyroid carcinoma

open access: yesExpert Review of Anticancer Therapy, 2023
Medullary thyroid carcinoma (MTC) constitutes approximately 5-10% of all thyroid cancers. Although the tumor forms in the thyroid, it doesn't originate from thyroid cells, but from the C cells or parafollicular cells which produce and release a hormone called calcitonin (CT). Starting from the second half of the 1900s, MTC was progressively studied and
Pelizzo, Maria Rosa   +3 more
semanticscholar   +5 more sources

Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumor with lymph node metastasis: A case report [PDF]

open access: yesJournal of Medical Case Reports, 2011
Introduction Papillary thyroid carcinoma and medullary thyroid carcinoma are two different thyroid neoplasia. The simultaneous occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma as a collison tumor with metastases from both lesions
Sadat Alavi Mehr, Azarpira Negar
doaj   +4 more sources

Melanotic medullary carcinoma of thyroid – report of a rare case with brief review of literature [PDF]

open access: yesDiagnostic Pathology, 2008
Background Melanin production in medullary carcinoma is extremely uncommon. Case presentation We report a rare variant of medullary carcinoma of thyroid with melanin production in a 52-year-old woman who presented with swelling in the thyroid of 3 months
Jain Deepali   +3 more
doaj   +4 more sources

Medullary Thyroid Carcinoma Without Calcitonin: A Case Linking Ultimobranchial Bodies to Tumor Evolution [PDF]

open access: yesPathophysiology
Medullary thyroid carcinoma (MTC) is a thyroid tumor with neuroendocrine properties purportedly derived from C-cells. The biochemical activity of medullary thyroid carcinoma includes the production of calcitonin and carcinoembryonic antigen, which are ...
Ion Prisneac   +3 more
doaj   +2 more sources

Sporadic Medullary Microcarcinoma in a Young Patient - A Rare Case [PDF]

open access: yesOnline Journal of Health & Allied Sciences, 2010
Sporadic medullary microcarcinoma of thyroid is a rare disease detected usually in 0.15% of all thyroid malignancy. We report a case of sporadic medullary microcarcinoma (MMC) of thyroid in a 24 year old male presenting as solitary thyroid nodule.
Vijayshankar S   +3 more
doaj   +2 more sources

Medullary Thyroid Carcinoma [PDF]

open access: yesScandinavian Journal of Surgery, 2004
Medullary thyroid carcinoma (MTC) is subdivided into sporadic (75%) and hereditary (25%) forms. Several germline mutations in the RET proto-oncogene are the source of distinct clinical phenotypes in hereditary MTC including familial MTC (FMTC) and multiple endocrine neoplasia 2A (MEN 2A) and 2B (MEN 2B).
M, Brauckhoff   +5 more
  +8 more sources

Rare Mixed Thyroid Carcinomas: A Report of Two Cases [PDF]

open access: yesIranian Journal of Otorhinolaryngology, 2022
Introduction:Thyroid cancers constitute 0.5%- 1% of all cancers of which differentiated cancers are most common. Mixed thyroid carcinomas are rare entities comprising only 0.5% of thyroid cancers. These tumours pose challenges in diagnosis by fine needle
Nitya Subramanian   +3 more
doaj   +1 more source

Thyroid: Medullary carcinoma [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2013
Medullary thyroid cancers (MTC) are rare neuroendocrine tumors arising from the parafollicular C-cells of the thyroid. In this review, we provide a general overview of the classification, pathology, and clinical management of MTC. In the latter half, we survey the underlying genetic framework of MTC and its potential implications within a diagnostic ...
Somnay, Y, Schneider, D, Mazeh, H
openaire   +3 more sources

Medullary thyroid carcinoma

open access: yesCurrent Opinion in Endocrinology, Diabetes & Obesity, 2021
Purpose of review To summarize recent developments in the diagnosis and management of patients with medullary thyroid cancer (MTC), with a focus on pathogenesis, systemic therapy, and future directions. Recent findings The addition of mutational analysis to cytological assessment of
Tania, Jaber, Ramona, Dadu, Mimi I, Hu
openaire   +3 more sources

Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys

open access: yesFrontiers in Endocrinology, 2022
Thyroid cancer is the malignant tumor that is increasing most rapidly in the world, mainly at the expense of sporadic papillary thyroid carcinoma. The somatic alterations involved in the pathogenesis of sporadic follicular cell derived tumors are well ...
María Sánchez-Ares   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy